SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS)

$0 None (None%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 66

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) News Sources

Shanghai Junshi Biosciences (SEHK:1877) Valuation Check After Mixed One Year And Three Year Returns

25-03-2026

yahoo.com

Junshi Biosciences Announces 2025 Full Year Financial Results and Provides Corporate Updates

13-03-2026

yahoo.com

Junshi Biosciences Announces NMPA Acceptance of New Drug Applications for Toripalimab Injection (Subcutaneous) Across 12 Indications

09-03-2026

yahoo.com

Antengene Announces Clinical Collaboration with Junshi Biosciences to Explore the Synergistic Potential of ATG-037 (Oral CD73 Inhibitor) In Combination with JS207 (PD-1/VEGF BsAb)

25-02-2026

yahoo.com

Junshi Biosciences Announces Strategic Collaboration with Antengene to Evaluate Combination Therapy with JS207 (PD-1/VEGF BsAb) and ATG-037 (Oral CD73 Inhibitor)

25-02-2026

yahoo.com

Shanghai Junshi Biosciences (SEHK:1877): Revisiting Valuation After a Volatile Share Price Rebound

08-12-2025

yahoo.com

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

06-12-2025

yahoo.com

Junshi Biosciences Announces Acceptance of the NDA for Roconkibart (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis

05-12-2025

yahoo.com

Junshi Biosciences Announces Primary Endpoints Met in JS001sc’s Phase 3 Study for the 1ST-line Treatment of NSQ-NSCLC

25-11-2025

yahoo.com

Junshi Biosciences Announces FDA’s Approval of IND Application for Phase 2/3 Clinical Study of JS207 for the Neoadjuvant Treatment of NSCLC Patients

17-10-2025

yahoo.com

SHJBF stock
SHJBF stock price
SHJBF stock price today
SHJBF stock prediction
SHJBF earnings date
SHJBF news
SHJBF price
SHJBF share
SHJBF share price
SHJBF shares
SHJBF ceo
SHJBF premarket
$SHJBF
SHJBF ticker
SHJBF after hours
SHJBF stock
SHJBF stock price
SHJBF stock price today
SHJBF stock prediction
SHJBF earnings date
SHJBF news
SHJBF price
SHJBF share
SHJBF share price
SHJBF shares
SHJBF ceo
SHJBF premarket
$SHJBF
SHJBF ticker
SHJBF after hours

SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) Sentiment Trend

View FAQ

SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) FAQs

toggle

What is the current price of SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS)?

The current price of SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) is $0.


toggle

SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) since the previous trading day is $None.


toggle

SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) since the previous trading day is None%.


toggle

What is the most recent average sentiment score for SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS)?

The most recent average sentiment score for SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) is 66 out of 100.


toggle

What is the most recent average sentiment for SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS)?

The most recent sentiment for SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) is .


SEC-8K** Filing Available For SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.